DEEL is a Singapore-based startup in the biotechnology and healthcare industries, with a focus on paving the way for innovation in healthcare and access to affordable and quality products. The company emphasizes reaching out to prospective manufacturers and customers through diverse channels, especially for specialized and novel therapies and products. DEEL's competent team of sales professionals is dedicated to building great customer relationships, while the highly qualified and specialized team of marketing professionals is dedicated to brand management, ensuring the best of promotional initiatives are in place. The company's slogan "Matter of Quality" reflects its commitment to providing high-quality products and services.
DEEL's innovative approach to addressing unmet needs in healthcare presents an opportunity for maximizing value in the growing healthcare market. However, detailed information regarding the company's founding date, last investment, and investors is currently unavailable.
With its focus on specialized and novel therapies, DEEL's potential for growth and disruption in the healthcare industry makes it an attractive prospect for potential venture capital investment. The company's presence in Singapore also offers strategic advantages as the country continues to position itself as a hub for healthcare and biotechnology innovation.
There is no investment information
No recent news or press coverage available for DEEL.